Cadmium exposure in relation to insulin production, insulin sensitivity and type 2 diabetes: A cross-sectional and prospective study in women

Environmental Research

Volumn 121, Issue , 2013, Pages 104-109

  Barregard, Lars ^a   Bergström, Göran ^b   Fagerberg, Björn ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Cadmium; Glucose tolerance; Insulin resistance; Insulin secretion; Type 2 diabetes

Indexed keywords

CADMIUM; CREATININE; HEMOGLOBIN A1C; INSULIN;

BLOOD; CADMIUM; DIABETES; ENZYME; GLUCOSE; HEALTH RISK; HORMONE; POLLUTION EXPOSURE; SAMPLING; SECRETION; TEMPORAL ANALYSIS; TOLERANCE; URINE; WOMENS HEALTH;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD LEVEL; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; CROSS-SECTIONAL STUDY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; HUMAN TISSUE; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; URINE LEVEL;

CADMIUM; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; ENVIRONMENTAL EXPOSURE; FEMALE; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84873990359     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2012.11.005     Document Type: Article

References (34)

1. Akesson A., Julin B., Wolk A. Long-term dietary cadmium intake and postmenopausal endometrial cancer incidence: A population-based prospective cohort study. Cancer Res. 2008, 68:6435-6441.
2. Abdul-Ghani M.A., Tripathy D., DeFronzo R.A. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 2006, 29:1130-1139.
3. Afridi H.I., Kazi T.G., Kazi N., Jamali M.K., Arain M.B., Jalbani N., et al. Evaluation of status of toxic metals in biological samples of diabetes mellitus patients. Diabetes Res. Clin. Pract. 2008, 80:280-288.
4. Behre C.J., Brohall G., Hulthe J., Wikstrand J., Fagerberg B. Are serum adiponectin concentrations in a population sample of 64-year-old Caucasian women with varying glucose tolerance associated with ultrasound-assessed atherosclerosis?. J. Intern. Med. 2006, 260:238-244.
5. Bingley P.J., Bonifacio E., Mueller P.W. Diabetes antibody standardization program: First assay proficiency evaluation. Diabetes 2003, 52:1128-1136.
6. Brohall G., Behre C.J., Hulthe J., Wikstrand J., Fagerberg B. Prevalence of diabetes and impaired glucose tolerance in 64-year-old Swedish women: Experiences of using repeated oral glucose tolerance tests. Diabetes Care 2006, 29:363-367.
7. DECODE Study Group Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 2003, 26:61-69.
8. Edwards J.R., Prozialeck W.C. Cadmium, diabetes and chronic kidney disease. Toxicol. Appl. Pharmacol. 2009, 238:289-293.
9. Englund Ogge L., Brohall G., Behre C.J., Schmidt C., Fagerberg B. Alcohol consumption in relation to metabolic regulation, inflammation, and adiponectin in 64-year-old Caucasian women: A population-based study with a focus on impaired glucose regulation. Diabetes Care 2006, 29:908-913.
10. Engström A., Michaëlsson K., Suwazono Y., Wolk A., Vahter M., Akesson A. Long-term cadmium exposure and the association with bone mineral density and fractures in a population-based study among women. J. Bone Miner. Res. 2011, 26:486-495.
11. Ezaki O. IIb group metal ions (Zn2+, Cd2+, Hg2+) stimulate glucose transport activity by post-insulin receptor kinase mechanism in rat adipocytes. J. Biol. Chem. 1989, 264:16118-16122.
12. Fagerberg B., Kellis D., Bergström G., Behre C.J. Adiponectin in relation to insulin sensitivity and insulin secretion in the development of type 2 diabetes: A prospective study in 64-year-old women. J. Intern. Med. 2011, 269:343-636.
13. Fagerberg, B., Bergström, G., Borén, J., Barregard, L., 2012. Cadmium exposure is accompanied by increased prevalence and future growth of atherosclerotic plaques in 64-year-old women. J Intern Med. [Epub ahead of print]. http://dx.doi.org/%2010.1111/j.1365-2796.2012.02578.
14. FAO/WHO. Food and agriculture organization of the United Nations and World Health Organization. 2011. Safety evaluation of certain food additives and contaminants. WHO Food Additives Series: 64. Geneva.
15. Ferraro P.M., Costanzi S., Naticchia A., Sturniolo A., Gambaro G. Low level exposure to cadmium increases the risk of chronic kidney disease: Analysis of the NHANES 1999-2006. BMC Public Health 2010, 10:304.
16. Gallagher C.M., Kovach J.S., Meliker J.R. Urinary cadmium and osteoporosis in U.S. women ≥50 years of age: NHANES 1988-1994 and 1999-2004. Environ. Health Perspect. 2008, 116:1338-1343.
17. Harrison S.A., Buxton J.M., Clancy B.M., Czech M.P. Evidence that erythroid-type glucose transporter intrinsic activity is modulated by cadmium treatment of mouse 3T3-L1 cells. J. Biol. Chem. 1991, 266:19438-19449.
18. Hu G., DECODE Study Group Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes. Diabetologia 2003, 46:608-617.
19. Julin B., Wolk A., Bergkvist L., Bottai M., Akesson A. Dietary cadmium exposure and risk of postmenopausal breast cancer: A population-based prospective cohort study. Cancer Res. 2012, 72:1459-1466.
20. Järup L., Akesson A. Current status of cadmium as an environmental health problem. Toxicol. Appl. Pharmacol. 2009, 238:201-208.
21. Kawakami T., Sugimoto H., Furuichi R., Kadota Y., Inoue M., Setsu K., et al. Cadmium reduces adipocyte size and expression levels of adiponectin and Peg1/Mest in adipose tissue. Toxicology 2010, 267:20-26.
22. Mannino D.M., Holguin F., Greves H.M., Savage-Brown A., Stock A.L., Jones R.L. Urinary cadmium levels predict lower lung function in current and former smokers: Data from the Third National Health and Nutrition Examination Survey. Thorax 2004, 59:194-198.
23. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
24. Nilsson T., Berggren P.O., Hellman B. Cadmium-induced insulin release does not involve changes in intracellular handling of calcium. Biochim. Biophys. Acta 1987, 929:81-87.
25. Nordberg G.F., Nogawa K., Nordberg M., Friberg L. Cadmium. Handbook on the Toxicology of Metals 2007, 445-486. Elsevier, Amsterdam. G.F. Nordberg, G.F. Fowler, M. Nordberg, L. Friberg (Eds.).
26. Pratley R.E., Weyer C. The role of impaired early insulin secretion in the pathogenesis of typ II diabetes. Diabetologia 2001, 44:929-945.
27. Sandbaek A., Lauritzen T., Borch-Johnsen K., Mai K., Christiansen J.S. The comparison of venous plasma glucose and whole blood capillary glucose in diagnoses of Type 2 diabetes: A population-based screening study. Diabet. Med. 2005, 22:1173-1177.
28. Schwartz G.G., Il'yasova D., Ivanova A. Urinary cadmium, impaired fasting glucose, and diabetes in the NHANES 1988-1994. Diabetes Care 2003, 26:468-470.
29. Swaddiwudhipong W., Mahasakpan P., Limpatanachote P., Krintratun S. Correlations of urinary cadmium with hypertension and diabetes in persons living in cadmium-contaminated villages in northwestern Thailand: A population study. Environ. Res. 2010, 110:612-616.
30. Swaddiwudhipong W., Limpatanachote P., Nishijo M., Honda R., Mahasakpan P., Krintratun S. Cadmium-exposed population in Mae Sot district, Tak province: 3. Associations between urinary cadmium and renal dysfunction, hypertension, diabetes, and urinary stones. J. Med. Assoc. Thai 2010, 93:231-238.
31. Swaddiwudhipong W., Limpatanachote P., Mahasakpan P., Krintratun S., Punta B., Funkhiew T. Progress in cadmium-related health effects in persons with high environmental exposure in northwestern Thailand: A five-year follow-up. Environ. Res. 2012, 112:194-198.
32. Tellez-Plaza M., Navas-Acien A., Menke A., Crainiceanu C.M., Pastor-Barriuso R., Guallar E. Cadmium exposure and all-cause and cardiovascular mortality in the U.S. General population. Environ. Health Perspect. 2012, 120:1017-1022.
33. Vuori E., Huunan-Seppälä A., Kilpiö J.O., Salmela S.S. Biologically active metals in human tissues. II. The effect of age on the concentration of cadmium in aorta, heart, kidney, liver, lung, pancreas and skeletal muscle. Scand. J. Work Environ. Health 1979, 5:16-22.
34. WHO. World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Report of WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, WHO, 1999.